SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001100412-19-000005
Filing Date
2019-02-05
Accepted
2019-02-05 08:07:03
Documents
67
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q a12311810-q.htm 10-Q 1348104
2 EXHIBIT 31.1 a123118ex311.htm EX-31.1 14803
3 EXHIBIT 31.2 a123118ex312.htm EX-31.2 14050
4 EXHIBIT 32.1 a123118ex321.htm EX-32.1 11771
11 arraylogo2018a12.jpg GRAPHIC 146580
12 braftovimektovirrgba01.jpg GRAPHIC 224279
  Complete submission text file 0001100412-19-000005.txt   7870286

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT arry-20181231.xml EX-101.INS 1711136
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arry-20181231.xsd EX-101.SCH 47883
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT arry-20181231_cal.xml EX-101.CAL 67110
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT arry-20181231_def.xml EX-101.DEF 318082
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arry-20181231_lab.xml EX-101.LAB 665106
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arry-20181231_pre.xml EX-101.PRE 428695
Mailing Address 3200 WALNUT STREET BOULDER CO 80301
Business Address 3200 WALNUT STREET BOULDER CO 80301 3033816600
ARRAY BIOPHARMA INC (Filer) CIK: 0001100412 (see all company filings)

IRS No.: 841460811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-16633 | Film No.: 19566283
SIC: 2834 Pharmaceutical Preparations